openPR Logo
Press release

Anatomic Pathology Market to Attract a Revenue of US$ 30,314.5 Million by 2025-End

09-05-2018 04:03 PM CET | Health & Medicine

Press release from: Transparency Market Research

Anatomic Pathology Market to Attract a Revenue of US$ 30,314.5

The anatomic pathology market worldwide is experiencing stiff competition because of the presence of numerous large companies and a handful of regional players challenging their might in the local pockets. In order to thrive in such a cutthroat environment, players are seen ramping up expenditure in research and development of disease indications.

Read Report Overview @ https://www.transparencymarketresearch.com/anatomic-pathology-market.html

Some of the key companies operating in the global anatomic pathology market are Abbott Laboratories, Laboratory Corporation of America Holdings, Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, NeoGenomics Laboratories Inc., Agilent Technologies Inc., Sakura Finetek USA Inc., and F. Hoffmann-La Roche Ltd.

The market for anatomic pathology worldwide will likely rise at a steady pace of 6.5% during the period from 2017 to 2025, predicts a report by Transparency Market Research. At this pace, the market is projected to clock a value of US$30,314.5 mn by 2025-end from US$17,318.0 mn in 2016.

Depending upon products and services, the global market for anatomic pathology can be segmented into consumables, instruments, and services. The segment of instruments can be divided further into tissue processor, microtomes, slide strainer, etc. The services segment, among them, leads the market at present on account of the rising instances of critical illnesses needing urgent medical attention. In 2016, it accounted for a significant 45.9% share in the market.

Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23774

Geographically, North America holds is a leading position in the market and in 2016 held a substantial 40.0% share in it. The region’s dominance is mainly because of a large pool of elderly who are highly susceptible to various diseases and the growing occurrence of chronic diseases. A superior healthcare infrastructure and affordable yet quality treatment options too are having a positive impact on the market.

Anatomic pathology serves to uncover abnormalities which in turn enables detection of various diseases and carry out treatments. Therefore, anatomic pathology is finding rising application in uncovering and managing different kinds of cancers and tumors. Alarming increase in the number of such deadly medical conditions is one of the main factors boosting the market for anatomic pathology.

Apart from the increasing prevalence of such chronic conditions, rising spends on healthcare, a burgeoning elderly population, and rising use and effectiveness of biomarkers for diagnosis of diseases is also bolstering the market for anatomic pathology. Further, continued progress on the technological front, leading to more sophisticated anatomic pathology methods has benefitted the demand in the market as well. This is particularly true of developed countries in the world which typically earmark considerable amounts on research and development in the domain of disease diagnosis and treatment. Not to be left behind, developing countries too are adding to the demand in the market on the back of initiatives by governments to generate awareness about new cutting-edge technologies.

Request for the Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23774

Currently, the end-use segment of diagnostic center is generating maximum demand in the market because of their low cost. Going forward, the segment will likely progress at an impressive pace due to the extensive usage of anatomic assays and easy availability of novel molecular testing instruments and anatomic pathology testing kits which help to detect cancer at reduced costs. Hospitals and research organizations are other key end-use segments driving demand in the market for anatomic pathology.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anatomic Pathology Market to Attract a Revenue of US$ 30,314.5 Million by 2025-End here

News-ID: 1222428 • Views: 128

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Anatomic

Global Anatomic Pathology Market Research Report
This report studies the global Anatomic Pathology market status and forecast, categorizes the global Anatomic Pathology market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Agilent Technologies, Inc. Bio SB Biogenex Laboratories Danaher Corporation F. Hoffmann-La Roche AG. Laboratory Corporation of America
Anatomic Pathology Market - Key strategies 2017-2025
Global Anatomic Pathology Market: Overview Anatomic pathology finds application in diagnosis of different types of chronic diseases, namely cancer and infectious diseases. It is also used in pharmaceutical industries to carry out toxicology studies. It is a medical specialty that diagnoses a disease based on microscopic, macroscopic, biochemical, immunologic, and molecular scrutiny of organs and tissues. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2156 Driving growth in the global anatomic pathology
Anatomic Pathology Market Foster the Growth over 2025
Global Anatomic Pathology Market: Overview Anatomic pathology finds application in diagnosis of different types of chronic diseases, namely cancer and infectious diseases. It is also used in pharmaceutical industries to carry out toxicology studies. It is a medical specialty that diagnoses a disease based on microscopic, macroscopic, biochemical, immunologic, and molecular scrutiny of organs and tissues. Driving growth in the global anatomic pathology market is the rising elderly population, increasing
Anatomic Pathology Market - Future Trends Forecast 2017 - 2025
Global Anatomic Pathology Market: Overview Anatomic pathology finds application in diagnosis of different types of chronic diseases, namely cancer and infectious diseases. It is also used in pharmaceutical industries to carry out toxicology studies. It is a medical specialty that diagnoses a disease based on microscopic, macroscopic, biochemical, immunologic, and molecular scrutiny of organs and tissues. Driving growth in the global anatomic pathology market is the rising elderly population, increasing
Anatomic Pathology Market Set to Surge Significantly During 2025
The global anatomic pathology market is choc-o-bloc with companies with several large global players and a few local players, reports Transparency Market Research (TMR) in a new market study. This renders a stiff vendor landscape wherein companies are pouring in money into research and development for disease indication that will help them stay ahead in the game. Prominent participants in the global anatomic pathology market include Abbott Laboratories, Danaher Corporation, Laboratory
Anatomic Pathology Market worth over USD 22 billion By 2022
Anatomic pathology market Analysis, by Type (instruments, consumables and services), by Application (disease diagnostic (cancer, lymphoma and others), drug discovery and developments) By Key Companies- (Abbott Diagnostics Agilent Technologies Danaher Roche Diagnostics & others), by end users Forecast to 2022 Market Synopsis of Global Anatomic Pathology Market: Market Scenario: Anatomical pathology or commonwealth is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and